Article
Neurosciences
Alshimaa Magdy, Eman A. E. Farrag, Shereen Mohamed Hamed, Zienab Abdallah, Eman Mohamad El Nashar, Mansour Abdullah Alghamdi, Amira A. H. Ali, Marwa Abd El-kader
Summary: Parkinson's disease (PD) is the second most common neurodegenerative disease, and current treatment strategies only provide symptomatic relief. Recent studies have shown that calcitriol, a form of vitamin D3, has neuroprotective effects in PD by modulating autophagy and the Sirt1/NF-kappa B pathway. This study demonstrated that calcitriol administration improved behavioral impairments and dopaminergic neuron depletion in a rotenone-induced PD model, and attenuated neuroinflammation and autophagy dysfunction. These findings suggest that calcitriol may have a neuroprotective and restorative effect in PD.
FRONTIERS IN CELLULAR NEUROSCIENCE
(2022)
Article
Neurosciences
Shubhendu M. Shirgadwar, Rahul Kumar, Kumari Preeti, Dharmendra Kumar Khatri, Shashi Bala Singh
Summary: This study evaluated the neuroprotective potential of phloretin (PLT) in Parkinson's disease (PD) by modulating the autophagy-antioxidant axis. The results showed that PLT improved locomotive activity and anxiety-like behavior in mice, reduced apoptosis and α-Synuclein expression, and improved the expression of TH and antioxidant proteins. This study provides evidence for PLT as a potential disease-modifying drug for PD management.
JOURNAL OF ALZHEIMERS DISEASE
(2023)
Article
Neurosciences
Heba Fikry, Lobna A. Saleh, Sara Abdel Gawad
Summary: This study investigated the protective influence of curcumin on the cerebellum of rats with rotenone-induced Parkinson's disease. The results showed that curcumin could alleviate degenerative changes and neurotoxic effects in the cerebellum, as well as reduce oxidative stress. This suggests that dietary supplementation of curcumin may have neuroprotective effects against cerebellum-related Parkinson's disease symptoms.
CNS NEUROSCIENCE & THERAPEUTICS
(2022)
Article
Pharmacology & Pharmacy
Christine N. Habib, Mohamed R. Mohamed, Mariane G. Tadros, Mai F. Tolba, Esther T. Menze, Somia Masoud
Summary: The study found that diosmin (DM) has neuroprotective effects in Parkinson's disease (PD) and can act through various mechanisms such as anti-inflammatory and antioxidative properties. These findings suggest that DM may be a promising candidate for managing the neuropathological course of PD.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Khalid A. El-Saiy, Rabab H. Sayed, Ayman E. El-Sahar, Esraa A. Kandil
Summary: This study found that venlafaxine can inhibit HDAC6 and enhance alpha-synuclein clearance, improving motor and non-motor symptoms of Parkinson's disease (PD). It also restores histone-3 acetylation and increases survival gene expressions. Additionally, venlafaxine inhibits depressive symptoms and improves neurotransmitter levels in the hippocampus.
CHEMICO-BIOLOGICAL INTERACTIONS
(2022)
Article
Environmental Sciences
Rajan Kumar, Rakesh Kumar, Navneet Khurana, Sachin Kumar Singh, Shelly Khurana, Surajpal Verma, Neha Sharma, Manish Vyas, Kamal Dua, Rubiya Khursheed, Ankit Awasthi, Sukriti Vishwas
Summary: In this study, a self-nanoemulsifying drug delivery system (SNEDDS) of fisetin, a polyphenolic flavonoid, was developed to enhance its solubility and bioavailability. The SNEDDS formulation significantly improved the rotenone-induced behavioral changes in rats compared to naive fisetin, indicating its potential as an anti-Parkinsonian agent.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
(2022)
Article
Plant Sciences
Yu Zhang, Sheng Li, Liyan Hou, Mingyang Wu, Jianing Liu, Ruonan Wang, Qingshan Wang, Jie Zhao
Summary: Research found that SVHRSP, a single component extracted from scorpion venom, has neuroprotective effects in Parkinson's disease. The study further discovered that SVHRSP achieves neuroprotection by inhibiting microglia-mediated neuroinflammatory pathways.
JOURNAL OF ETHNOPHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Leilei Chen, Yujv Huang, Xing Yu, Jiahong Lu, Wenting Jia, Juxian Song, Liangfeng Liu, Youcui Wang, Yingyu Huang, Junxia Xie, Min Li
Summary: Cory from Uncaria rhynchophylla has been shown to exhibit neuroprotective effects in rotenone-induced PD animal models by reducing neuroinflammation and diminishing alpha-synuclein aggregates through various pathways.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Neurosciences
Ismail Unal, Derya Cansiz, Merih Beler, Zehra Sezer, Elif Guzel, Ebru Emekli-Alturfan
Summary: In this study, the effects of the SGLT2 inhibitor empagliflozin (EMP) on a zebrafish model of Parkinson's disease (PD) were evaluated. The results showed that EMP treatment improved neurofunction, autophagy, and the expression of inflammation-related genes, as well as reduced oxidative damage, mimicking the effects of a ketogenic diet.
Article
Immunology
Shipra Kartik, Rishi Pal, Manju J. Chaudhary, Rajendra Nath, Madhu Kumar, Monika Binwal, D. U. Bawankule
Summary: Parkinson's disease is a neuro-motor ailment that causes motor and non-motor impairments. Recent research suggests that the disease is related to dysregulated autophagy and cerebral inflammation. Chloroquine, an anti-malarial drug, has been shown to inhibit autophagy in various diseases, including Parkinson's.
INFLAMMOPHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Olga Kulikova, Dmitry Troshev, Daniil Berezhnoy, Sergey Stvolinsky, Yulia Timoshina, Denis Abaimov, Olga Muzychuk, Alexander Latanov, Tatiana Fedorova
Summary: Oxidative stress and mitochondrial dysfunction are important mechanisms in the pathogenesis of PD. Carnosine and lipoic acid have potent antioxidant properties, but their effectiveness is limited due to poor bioavailability. This study evaluated the neuroprotective effects of a nanomicellar complex of carnosine and lipoic acid (CLA) in a rat model of PD induced by rotenone. Results showed that CLA reduced muscle rigidity, restored locomotor activity, increased brain tissue antioxidant activity, neuron density in the substantia nigra, and dopamine levels in the striatum. These findings suggest that CLA has neuroprotective properties and may be beneficial in combination with standard therapy for PD.
Article
Immunology
Rehab M. El-Sayed, Ahmed M. Abdelaziz, Hala F. Zaki, Nora O. Abdel Rasheed
Summary: This study investigated the neuroprotective effect of cilostazol on rotenone-intoxicated rats focusing on the HMGB1/TLR4 axis, Nrf2/HO-1, and PI3K/Akt/mTOR pathway. Cilostazol significantly improved neurobehavioral analysis, histopathological examination, and dopamine levels. These effects were associated with enhancement of Nrf2 and HO-1 expression, repression of the HMGB1/TLR4 pathway, and upregulation of PI3K/Akt expression.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Hai-Jun He, Xi Xiong, Shuoting Zhou, Xing-Ru Zhang, Xuemiao Zhao, Lingli Chen, Cheng-Long Xie
Summary: The study shows that curcumin has neuroprotective effects in Parkinson's disease, both in vitro and in vivo. It inhibits cell apoptosis and induces autophagy through the AKT/mTOR signaling pathway. This leads to reduced accumulation of α-synuclein and improved parkinsonian disability scores.
NEUROCHEMISTRY INTERNATIONAL
(2022)
Article
Biochemistry & Molecular Biology
Ramesh Pariyar, Tonking Bastola, Dae Ho Lee, Jungwon Seo
Summary: The anti-diabetic drug vildagliptin has been found to have protective effects against motor dysfunction caused by Parkinson's disease (PD), potentially through the regulation of PI3k/Akt, ERK, and JNK signaling pathways.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Chemistry, Medicinal
Aya M. Abd El-Latif, Mostafa A. Rabie, Rabab H. Sayed, Mai A. Abd El Fattah, Sanaa A. Kenawy
Summary: Growing evidence suggests that impaired autophagy mediated by AMPK activation plays a crucial role in the pathophysiology of Parkinson's disease. Inosine, with its neuroprotective, anti-inflammatory, and antioxidant properties, was found to improve motor function and restore neuronal activity in rotenone-induced PD rats by activating AMPK and enhancing autophagy. These findings support the potential application of inosine in the treatment of Parkinson's disease.
DRUG DEVELOPMENT RESEARCH
(2023)